JPMorgan Chase & Co’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.55M | Buy |
331,957
+66,462
| +25% | +$1.91M | ﹤0.01% | 2254 |
|
|
2025
Q1 | $8.9M | Sell |
265,495
-4,048
| -2% | -$136K | ﹤0.01% | 2265 |
|
|
2024
Q4 | $13.8M | Sell |
269,543
-16,413
| -6% | -$839K | ﹤0.01% | 2010 |
|
|
2024
Q3 | $14.6M | Buy |
285,956
+894
| +0.3% | +$45.7K | ﹤0.01% | 1914 |
|
|
2024
Q2 | $12.8M | Sell |
285,062
-90,924
| -24% | -$4.07M | ﹤0.01% | 1941 |
|
|
2024
Q1 | $17.6M | Buy |
375,986
+282,882
| +304% | +$13.2M | ﹤0.01% | 1768 |
|
|
2023
Q4 | $3.31M | Buy |
93,104
+38,674
| +71% | +$1.38M | ﹤0.01% | 2822 |
|
|
2023
Q3 | $1.62M | Buy |
54,430
+10,756
| +25% | +$320K | ﹤0.01% | 3126 |
|
|
2023
Q2 | $787K | Buy |
43,674
+3,161
| +8% | +$57K | ﹤0.01% | 3561 |
|
|
2023
Q1 | $651K | Buy |
40,513
+5,819
| +17% | +$93.5K | ﹤0.01% | 3678 |
|
|
2022
Q4 | $636K | Buy |
34,694
+2,004
| +6% | +$36.7K | ﹤0.01% | 3629 |
|
|
2022
Q3 | $642K | Buy |
32,690
+1,801
| +6% | +$35.4K | ﹤0.01% | 3602 |
|
|
2022
Q2 | $576K | Sell |
30,889
-50,847
| -62% | -$948K | ﹤0.01% | 3792 |
|
|
2022
Q1 | $1.79M | Buy |
81,736
+33,463
| +69% | +$734K | ﹤0.01% | 3249 |
|
|
2021
Q4 | $1.37M | Buy |
48,273
+25,213
| +109% | +$717K | ﹤0.01% | 3477 |
|
|
2021
Q3 | $486K | Buy |
23,060
+2,919
| +14% | +$61.5K | ﹤0.01% | 3982 |
|
|
2021
Q2 | $379K | Sell |
20,141
-46,963
| -70% | -$884K | ﹤0.01% | 4151 |
|
|
2021
Q1 | $1.03M | Sell |
67,104
-11,904
| -15% | -$182K | ﹤0.01% | 3638 |
|
|
2020
Q4 | $1.11M | Buy |
79,008
+68,921
| +683% | +$972K | ﹤0.01% | 3313 |
|
|
2020
Q3 | $152K | Buy |
10,087
+952
| +10% | +$14.3K | ﹤0.01% | 3863 |
|
|
2020
Q2 | $160K | Buy |
9,135
+5,482
| +150% | +$96K | ﹤0.01% | 3766 |
|
|
2020
Q1 | $53K | Sell |
3,653
-106
| -3% | -$1.54K | ﹤0.01% | 4118 |
|
|
2019
Q4 | $95K | Buy |
3,759
+22
| +0.6% | +$556 | ﹤0.01% | 4045 |
|
|
2019
Q3 | $56K | Buy |
3,737
+704
| +23% | +$10.6K | ﹤0.01% | 4212 |
|
|
2019
Q2 | $75K | Buy |
3,033
+946
| +45% | +$23.4K | ﹤0.01% | 4108 |
|
|
2019
Q1 | $48K | Buy |
2,087
+307
| +17% | +$7.06K | ﹤0.01% | 4253 |
|
|
2018
Q4 | $53K | Buy |
1,780
+167
| +10% | +$4.97K | ﹤0.01% | 4242 |
|
|
2018
Q3 | $46K | Buy |
+1,613
| New | +$46K | ﹤0.01% | 4379 |
|